Accelerating healthcare towards proactive patient care with a reimbursable patient monitoring platform

Stasis Labs is an FDA cleared, remote patient monitoring system for in-facility and at-home patient care. The platform collects a patient's data in order to deliver insights for their improved recovery. The Stasis hardware measures six core vital signs, whilst its software gathers additional patient information which is all fed into a central dashboard, so clinicians always know the status of their patients. Stasis health insights provide relevant, timely information to the clinical team helping to keep at-risk patients safe and at home, avoiding unnecessary hospitalizations and visits to the doctor's office. The company is expanding its offering to enter the homes of patients in partnership with virtual care companies, aiming to provide top of the line chronic care management.

FOUNDED
2015

HEADQUARTERS
Boston, Massachusetts, United States

COMPANY SIZE
21–50

Michael Maylahn

Michael Maylahn (Cofounder & CEO at Stasis Labs) has been an Unreasonable Fellow since September 2020 and most recently participated in Unreasonable FUTURE 2020.

Unreasonable FUTURE 2020

Connect with Stasis Labs

Follow Stasis Labs on social media below.

  • Featured VentureAndiamo

  • Featured VentureAltaeros Energies